RAPT Therapeutics, Inc. (RAPT) Current Leases (2022 - 2024)
RAPT Therapeutics (RAPT) has disclosed Current Leases for 3 consecutive years, with $2.5 million as the latest value for Q3 2024.
- Quarterly Current Leases rose 5.56% to $2.5 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Sep 2024, up 5.56% year-over-year, with the annual reading at $2.4 million for FY2023, 12.76% up from the prior year.
- Current Leases hit $2.5 million in Q3 2024 for RAPT Therapeutics, down from $2.6 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $2.6 million in Q2 2024 to a low of $1.5 million in Q1 2022.
- Historically, Current Leases has averaged $2.2 million across 3 years, with a median of $2.3 million in 2023.
- Biggest five-year swings in Current Leases: soared 55.22% in 2023 and later increased 5.56% in 2024.
- Year by year, Current Leases stood at $2.2 million in 2022, then grew by 12.76% to $2.4 million in 2023, then rose by 3.06% to $2.5 million in 2024.
- Business Quant data shows Current Leases for RAPT at $2.5 million in Q3 2024, $2.6 million in Q2 2024, and $2.5 million in Q1 2024.